E Therapeutics Plc
Colin Stubberfield currently serves as Senior Vice President of Drug Discovery at PrecisionLife since February 2022. Prior to this role, Colin held the position of Principal Scientist at e-Therapeutics PLC from 2013 to the present. Colin's extensive experience in pharmacology includes serving as Director of Primary Pharmacology at UCB from 2003 to 2013 and Director of Drug Discovery at Oxford GlycoSciences from 1998 to 2003.
This person is not in any offices
E Therapeutics Plc
e-Therapeutics plc is a United Kingdom-based drug discovery and development company. The Company's discovery platform is based on the network of pharmacology and chemical biology. The Company operates in the business segment of drug discovery and devel...